Dignitana AB announces PDMR transaction

Dignitana AB announces that Dignitana Board member Fredrik Lindgren purchased 1 500 000 Dignitana AB shares in a PDMR transaction on 8 October 2024.

For More Information Contact 

Fredrik Jonsson, CEO, fredrik.jonsson@dignitana.com  +46 708766444

Klas Arildsson, Chairman of the Board of Directors, klas.arildsson@dignitana.com +46 709108003

About Dignitana

Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Scalp Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and patient comfort. Hailed internationally as a life-changing medical advancement for cancer patients, The DigniCap Scalp Cooling System was invented in 1999 by a Swedish Oncology nurse and has been available in Europe since 2001.  Dignitana AB is listed on Nasdaq First North Growth Market in Sweden with headquarters in Lund, Sweden and US operations based in Dallas, Texas in the United States.  Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Certified Adviser is Redeye AB. Learn more at www.dignitana.com or www.dignicap.com. 

Tags: